Otsuka Pharmaceutical Co Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Otsuka Pharmaceutical Co Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C0178
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mate protein jelly, metro mint, the calcium, oronine and new sararin, among others. Its pharmaceutical products are used in the areas of central nervous system, cardiovascular, circulatory disease, infectious diseases, kidney, digestive disease, ophthalmology and dermatology. The company operates in the US, Japan, Belgium, Australia, the UK, Denmark, and others. OPC is headquartered in Tokyo, Japan.

Otsuka Pharmaceutical Co Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Otsuka Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deal Details 11
Venture Financing 11
Megakaryon Raises USD9.7 Million in Series C Financing 11
Science 37 Raises USD35 Million in Series C Financing 13
Proteus Digital Health Raises US$63 Million In Series F Financing Round 14
Partnerships 15
Science 37 Enters into Agreement with Otsuka Pharma 15
C2N Diagnostics Enters Into Research Agreement With Cambridge Isotope Labs For Biomarkers 16
NuView Life Sciences Enters into Licensing Agreement with Otsuka Pharma for VPAC1 Biomarker 17
Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 18
Acquisition 19
Egypt Otsuka Pharmaceutical to Acquire 80% Stake in Ateco Pharma 19
Otsuka Pharmaceutical Co Ltd – Key Competitors 20
Otsuka Pharmaceutical Co Ltd – Key Employees 21
Otsuka Pharmaceutical Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 28
Recent Developments 29
Legal and Regulatory 29
Dec 13, 2017: Otsuka Pharmaceutical Unveils It’s Completely New Website 29
Other Significant Developments 30
Feb 28, 2018: Otsuka Encourages Start-Ups to Spark the Next Generation of Innovation and Collaboration in Mental Health Care 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Key Facts 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Otsuka Pharmaceutical Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Otsuka Pharmaceutical Co Ltd, Deals By Market, 2012 to YTD 2018 8
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Megakaryon Raises USD9.7 Million in Series C Financing 11
Science 37 Raises USD35 Million in Series C Financing 13
Proteus Digital Health Raises US$63 Million In Series F Financing Round 14
Science 37 Enters into Agreement with Otsuka Pharma 15
C2N Diagnostics Enters Into Research Agreement With Cambridge Isotope Labs For Biomarkers 16
NuView Life Sciences Enters into Licensing Agreement with Otsuka Pharma for VPAC1 Biomarker 17
Proteus Biomedical Enters Into Licensing Agreement With Otsuka Pharma 18
Egypt Otsuka Pharmaceutical to Acquire 80% Stake in Ateco Pharma 19
Otsuka Pharmaceutical Co Ltd, Key Competitors 20
Otsuka Pharmaceutical Co Ltd, Key Employees 21
Otsuka Pharmaceutical Co Ltd, Other Locations 22
Otsuka Pharmaceutical Co Ltd, Subsidiaries 22
Otsuka Pharmaceutical Co Ltd, Joint Venture 28

List of Figures
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Otsuka Pharmaceutical Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Otsuka Pharmaceutical Co Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Duke Energy Corp (DUK):石油・ガス:M&Aディール及び事業提携情報
    Summary Duke Energy Corp (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also procures …
  • Reliance Power Ltd (RPOWER):電力:M&Aディール及び事業提携情報
    Summary Reliance Power Ltd (RPower), formerly Reliance Energy Generation Private Limited, is a power generation and coal resources company. It develops, constructs, and operates power projects and coal mines. The company produces electricity from various sources of electricity including coal, solar …
  • Medigard Ltd (MGZ):医療機器:M&Aディール及び事業提携情報
    Summary Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd, is a medical device company that designs and develops retractable safety medical devices. The company provides products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and …
  • Check Point Software Technologies Ltd (CHKP):企業の財務・戦略的SWOT分析
    Check Point Software Technologies Ltd (CHKP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Umeme Limited (UMEME):企業の財務・戦略的SWOT分析
    Umeme Limited (UMEME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Beijing Beilu Pharmaceutical Co Ltd (300016):製薬・医療:M&Aディール及び事業提携情報
    Summary Beijing Beilu Pharmaceutical Co Ltd (Beijing BeiLu) is a manufacturer of traditional Chinese medicine preparation and psychiatric products. The company provides product portfolio such as contrast media products, anti anxiety medicines and oral antihyperglycemic agents, among others. Its cont …
  • Telefonaktiebolaget LM Ericsson:企業の戦略・SWOT・財務情報
    Telefonaktiebolaget LM Ericsson - Strategy, SWOT and Corporate Finance Report Summary Telefonaktiebolaget LM Ericsson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Second Genome Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Second Genome Inc (Second Genome), formerly PhyloTech Inc, is a clinical stage pharmaceutical company that provides microbial research and drug discovery services. The company’s pipeline products include SGM-1019, a small molecule inhibitor targeting tissue injury and inflammation; and SG-2- …
  • Domino’s Pizza, Inc.:企業の戦略・SWOT・財務情報
    Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report Summary Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tecrea Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Tecrea Ltd (Tecrea) is a cell and tissue delivery technology for research and drug development applications. The company develops Nanocin reagents and ingredients support research and development in academic and industrial research labs. It develops Nanocin-plasmid and Nanocin-RNA kits that …
  • Rigel Pharmaceuticals Inc (RIGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …
  • Smrt Corporation Ltd.:企業の戦略・SWOT・財務分析
    Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ceres Power Holdings plc (CWR):企業の財務・戦略的SWOT分析
    Summary Ceres Power Holdings Plc (Ceres Power) operates as an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power …
  • Investec Private Bank (UK & Europe):企業の戦略・SWOT・財務情報
    Investec Private Bank (UK & Europe) - Strategy, SWOT and Corporate Finance Report Summary Investec Private Bank (UK & Europe) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Pioneer Distilleries Limited:企業の戦略・SWOT・財務情報
    Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report Summary Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • HOK Group, Inc.:企業の戦略・SWOT・財務情報
    HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • MagForce AG (MF6):医療機器:M&Aディール及び事業提携情報
    Summary MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment. The company’s products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. Its NanoActivator creates a magnetic field that can be used to treat tumors in all areas …
  • Barrett Business Services Inc (BBSI):企業の財務・戦略的SWOT分析
    Summary Barrett Business Services Inc (BBSI) is a management consulting company that offers business management solutions. The company’s services include human capital management, preferred payroll, and staffing. Its payroll services handles deductions, liens, tax levies, tax payments, w-2s, and wag …
  • Unigroup Inc:企業の戦略・SWOT・財務分析
    Unigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Unigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Companhia Siderurgica Nacional:企業の戦略・SWOT・財務情報
    Companhia Siderurgica Nacional - Strategy, SWOT and Corporate Finance Report Summary Companhia Siderurgica Nacional - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆